Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Huiping Shi
Durable Molecular Remission in a Lymphoid BP-CML Patient Harboring T315I Mutation Treated With Anti-Cd19 CAR-T Therapy
OncoTargets and Therapy
Oncology
Pharmacology
Related publications
High Rate of Durable Complete Remission in Follicular Lymphoma After Cd19 Car-T Cell Immunotherapy
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Anti-Leukemic Activity of Axitinib Against Cells Harboring the BCR-ABL T315I Point Mutation
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
Product Characteristics Associated With in Vivo Expansion of Anti-Cd19 Car T Cells in Patients Treated With Axicabtagene Ciloleucel (Axi-Cel)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Durable Responses After CD19-targeted CAR-T Cell Immunotherapy With Concurrent Ibrutinib for CLL After Prior Ibrutinib Failure
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Toxicities of CD19 CAR-T Cell Immunotherapy
American Journal of Hematology
Hematology
CAR-T Cells Beyond CD19, UnCAR-Ted Territory
American Journal of Hematology
Hematology
Potent Anti-Leukemia Activities of Humanized CD19-targeted CAR-T Cells in Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia
American Journal of Hematology
Hematology
Efficacy and Safety of Humanized Anti-Cd19-Car-T Therapy Following Intensive Lymphodepleting Chemotherapy for Refractory/Relapsed B Acute Lymphoblastic Leukaemia
British Journal of Haematology
Hematology
OA07.05 Local Ablative Therapy Improves Survival in Patients With Synchronous Oligometastatic NSCLC Harboring EGFR Mutation Treated With EGFR-TKIs
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
